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The cellular constituents of synovial joint effusions of patients with rheuma-
toid arthritis present some curious features that may lead to an under-
standing of the nature of the disease. Effusions may be present constantly
for years, with the total and differential cell count remaining essentially
the same. If the fluid is removed by aspiration of the joint, the effusion
rapidly recurs and tends to resume its original cellular make-up. The cells
in the effusion are intriguing, because they are predominantly polymor-
phonuclear leukocytes in a chronic effusion in a disease in which the
synovial histological picture presents typical features of chronic inflam-
mation - lymphocytic and plasmocytic infiltration, chronic granulation
tissue, and fibrosis.
This paradox of a chronic effusion containing mostly polymorphonuclear
cells in a chronic inflammatory disease led us to postulate that these cells
were, in effect, sequestered in the synovial cavity in a relatively adynamic
state, with slow death of the exudative cells and a small daily replacement
from blood granulocytes. To test this hypothesis, a marrow cell population
of granulocytes was labeled by the induction of the enzyme dehydrofolate
reductase by the folic acid antagonist, amethopterin (methotrexate). Fol-
lowing injection of methotrexate, the enzyme accumulates in dividing
granulocyte precursors in the bone marrow, and their mature granulocyte
progeny emerge in the blood as cells with increased enzyme content. As
with other methods of bone marrow cell labeling, in normal subjects
enzyme-rich cells are detectable in the blood in 3 or 4 days, peak at 7 to 9
days, and decline rapidly over the next week.'
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Patients with rheumatoid arthritis were found to have essentially
normal granulocyte production, with peak levels in the blood at 7 to 9
days. If the granulocytes in the effusions were indeed sequestered and
adynamic, one would expect little labeling of cells in the effusion during the
"pulse" of enzyme-rich cells in blood. In the studies, however, blood and
synovial effusion leukocytes were sampled simultaneously after metho-
trexate injection and similar levels of enzyme were found in cells
from each source. This indicated that the cells in the effusions were far
TABLE 1. CLINICAL FEATURES OF PATIENTS IN THE STUDY
Synovial
Serum rheumatoid factor exudate
Sheep
cell Total
Patient Diagnosis Sex Latex (units) WBC/mm' %o Polys
A.K. R.A. F 1:160 32 29,900 85
M.O'B. R.A. F Pos. 128 26,000 43
W.A. R.A. M 1:160 7,700 81
I.R. R.A. F Neg. Neg. 50,800 86
L.T. R.A. M 1:320 10,400 51
S.O. R.A. M Neg. 11,800 74
E.B. R.A. F 1:160 128 32,900 89
B.P. R.A. F 1:80 32 12,400 76
A.J. R.A. F 1:640 128 11,100 90
G.D. Reiter's M Neg. 6,500 80
J.deL. Reiter's M Neg. 56,600 91
W.W.B. Ulc. colitis M Neg. 25,400 89
F.S. Gout M Neg. 24,800 95
N.B. Gout M 11,400 97
M.K. Gout F - 25,700 95
from adynamic, and were being regularly replaced by cells from the circula-
tion.'
These observations demonstrated that the turnover of cells in rheunmatoid
synovial effusions was quite rapid, probably within a matter of a day or
two. To more accurately define the rate of destruction of cells in the
effusions, a method of labeling cells within the effusion was needed. This
paper presents the results of tagging the cells in rheumatoid effusions with
isotopically labeled diisopropylfluorophosphate (DFP). To determine
whether the rapid turnover of granulocytes in synovial effusions of rheu-
matoid arthritis is unique to that disease, observations were made on a
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smaller number of patients with other, more acute, synovial inflammatory
diseases.
PATIENTS AND METHODS
Patients
Twelve experiments in nine patients with rheumatoid arthritis were performed. All
patients had chronic arthritis with the effusions present for months or years. To
compare with this group, three patients with acute gout, two with Reiter's syndrome,
and one with the arthritis of ulcerative colitis were studied. Certain clinical features
of the patients and of their synovial effusions are recorded in Table 1.
Standard clinical criteria (American Rheumatism Association) for the diagnosis of
rheumatoid arthritis were employed, and all patients had advanced disease at the
time of study. Serum rheumatoid factor was tested by the hospital laboratory, using
both the sensitized sheep cell and latex tests. The patients with gout had hyper-
uricemia and characteristic needle-like urate crystals in the synovial exudate. Two
patients with Reiter's syndrome had the classical triad of symptoms (arthritis and
conjunctivitis following nonspecific urethritis), and recovered from the episode
uneventfully in 3 to 6 months. The one patient with ulcerative colitis had associated
spondylitis with obliteration of the sacroiliac joints radiographically and recurring
synovitis of the knees.
Only patients who had knee joints with effusions in excess of 15 ml. in volume were
studied. The clinical estimation of the volume of effusion was usually checked at the
end of an experiment by complete aspiration of the joint.
Direct estimate of granulocyte lifespan by injection of labeled DFP into synovial
effusions.
Initially, DFPa was used in the studies, but later the tritium-labeled compound was
used because of its long radioactive half-life. Approximately 30 Uc of DFP8" (in 1 ml.
volumes) or 30-100 ,uc of DFP-H8 (in 0.03 to 0.1 ml. of propylene glycol) were
injected into the synovial exudate. To insure mixing, fluid was flushed back and
forth in the syringe several times, and after the isotope injection the patient was asked
to extend and flex his knee repeatedly. One hour was usually allowed for binding of
DFP to cellular and exudate proteins, and samples of 1 to 3 ml. volume were with-
drawn from the knee at intervals thereafter. After initial trials with varied time
intervals, a suitable sequence was found to be 1, 2, 4, 6 and 8 hours after injection.
The leukocytes were washed four times in saline and freed from any contaminating
erythrocytes incident to the puncture by lysing the latter with hypotonic saline. The
last wash contained only a trace of radioactivity. For the experiments with DFP',
the leukocytes were suspended in absolute ethanol, transferred to stainless steel
planchettes, and allowed to evaporate to dryness at room temperature. Radioactivity
was then measured with a Nuclear Chicago windowless gas-flow counter, and correc-
tions applied for radioactive decay. After the counting procedure was complete, the
residues in the planchettes were dissolved in sodium hydroxide solution (1 N) and
the nitrogen content estimated by the Kjeldahl and biuret methods. In studies with
DFP-H', saline-washed labeled leukocytes were washed with cold perchloric acid
(0.5M) to remove any small amounts of acid-soluble, presumably unbound, DFP, and
the residue suspended in 0.2 N sodium hydroxide solution. Aliquots of the suspension
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were counted in a Packard Tri-Carb Spectrometer with a toluene-ethanol scintillation
fluid containing p-bis (s-5-phenyloxazolyl)-benzene and 2,5-diphenyloxazole.' The
radioactivity derived from DFP-H8 was expressed on the basis of the total number
of leukocytes determined with a Coulter Model A particle counter. Radioactivity in
the cell-free synovial exudate was also measured in some experiments.
RESULTS
Effect of the multiple aspirations on the cellular composition of synovial
exudates
It was impossible to measure volume except by estimation, but none
of the patients exhibited any clinically detectable change during the 8-hour
period of most of the studies. Cell counts were obtained on almost all
TABLE 2. JOINT FLUID LEUKOCYTE COUNTS (CELLS/MM') IN SEQUENTIAL
SAMPLES DURING THE COURSE OF DFP STUDIES
Hours
Patient 1 2 3 4 5 6
B.P. 15,800 18,100 19,300 18,500
A.J. 12,200 9,700 10,800 9,600
I.R. 32,800 31,500 34,900 41,000
F.S. 19,200 16,200 15,200 12,600 12,500 16,100
J.deL. 56,600 52,400 73,600 54,200 51,800 54,600
N.B. 11,400 10,400 10,900 9,320 9,000
W.W.B. 24,300 21,600 20,800 22,400 21,400
M.K. 9,200 27,700 15,500 24,300
G.D. 5,080 3,200 4,700 3,700 3,300
of the samples in nine patients (Table 2). The first three patients in the
Table are those with rheumatoid arthritis, and their counts were quite
constant. One patient with Reiter's syndrome (G.D.) had a low initial
cell count that seemed to fall with time. Two of the patients with acute gout
(F.S. and N.B.) had surprisingly constant values, but the counts of
one (M.K.) varied unpredictably and her initial low count suggests a
laboratory error. Differential leukocyte counts were obtained in many of
these patients, and showed no significant alterations during the course
of the experiments.
Comparison of in vivo and in vitro labeling in one patient.
One patient was studied on three separate occasions. In one experiment
(#1 in patient A.K. in Table 3) 44 ml. of joint fluid was withdrawn
into a siliconized syringe containing 30 pc of DFP32 and incubated in
vitro for 30 minutes before the exudate was returned to the synovial cavity.
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In this experiment, blood leukocyte samples were assayed for p32 at the
same times as the joint fluid, and only a trace of cell-associated radio-
activity was detected.* The disappearance rate from this in vitro incuba-
tion experiment in this patient was similar to values obtained in two
later experiments in which the DFP was directly injected into the synovial
cavity (Table 3).
TABLE 3. Loss OF LABEL FROM CELLS IN SYNOVIAL EXUDATES
Date of
study
3-20-63*
5-20-63
2-11-64
4-24-63
5-17-63
5-17-63
3-24-64
6-18-63
6-18-63
6-18-63
3-18-64
3-18-64
7-28-65
8-3-64
2-19-65
6-4-64
2-12-65
3-18-65
Per cent of leukocyte radioactivity after
DFP injection (hours)
Isotope 0.5 1 2 3
Pu 100 67
P82 100 80
Ha 100 61
P8 100 80 52
P82 100 60
P82 100 70
H8 100 79 67
P82 100 62
P82 100 56
p88 100
H8 100 94
Ha 100 45
Hs 100 47 85
H8 100 107 78
H8 100 100 93
H8 100 72 65
HA 100 114 97
H8 100 47 25
4 5 6 7 8 9 24
31 42 6
45 46
23
56
63
57
57
20
55
63
30
53
53
95
55
59
33
40
57
49
22
16
19
40
35
51
72
51
43
2
3
28
18
27
0.5
10
* Isotope and exudate pre-incubated in vitro for 30 minutes before injection.
Loss of DFP-label from synovial exudate cells
In the 12 studies in patients with rheumatoid arthritis, 12 points
were obtained 3 hours after the isotope injection; 10 points at 5 hours;
* From a calculation of the total circulating granulocyte pool, the largest amount of
total blood leukocyte radioactivity (detected 30 minutes after the return of the
synovial fluid-DFP mixture to the joint cavity) represented only 3% of the cell-
associated DFP in the joint fluid. This slight blood cell activity probably represented
DFP not bound to protein or cells in the synovial fluid, but free to diffuse into the
circulation and attach to blood leukocytes. However, a small migration of cells back
from the synovial cavity into the blood cannot be excluded. In any event, the amount
of cell-associated label in blood leukocytes was so low that migration of tagged cells
from blood to synovial exudate would not have added detectably to the joint fluid
cell-associated radioactivity.
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M.O'B.
W.A.
I.R.
L.T.
S.O.
E.B.
B.P.
A.J.
G.D.
J.deL.
W.W.B.
F.S.
N.B.
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and 9 points at 7 hours. The mean values, with standard deviations, are
shown in Figure 1. In the effusions of patients with rheumatoid arthritis,
therefore, the granulocyte half-life seems about 4 hours. Although Figure
1 is plotted on an arithmetic scale on which the curvilinear disappearance
suggests a random destructive process, the actual data are too variable
to permit any statistical evaluation of the mechanism of destruction
(random destruction or finite lifespan).
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FIG. 1. Disappearance rate (mean + S.D.) of labeled granulocytes from synovial
effusions of patients with rheumatoid arthritis.
Although some of the patients had high titers of rheumatoid factor in
their serum and marked morphological changes of vacuolization and
degranulation in their synovial granulocytes, there was no gross difference
in loss of cell-associated labeled DFP between those patients and the ones
with negative rheumatoid factor tests and more normal granulocyte mor-
phology. The two patients, A.K. and I.R., in whom more than one deter-
mination was available, are good examples. Both had chronic knee effusions
present regularly for years and had similar rates of loss of cell label,
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although the sero-negative patient (I.R.) never showed morphological
changes on repeated examinations of exudative cells.
Similarly, of the three patients with overt gout and crystal phago-
cytosis only one (M.K.) seemed to have a somewhat rapid disappearance
of cell-bound radioactivity in the effusion. The two patients with Reiter's
disease (G.D. and J. deL.) also had loss of label from the cells in their
synovial exudates similar to that of the patients with rheumatoid arthritis
(Table 3).
DISCUSSION
To define further the rapidity of granulocyte destruction in rheuma-
toid effusions and to compare rheumatoid disease with other more acute
synovial effusions, a method was needed for direct labeling of cells
within the synovial cavity. Diisopropylfluorophosphate (DFP), labeled
with either phosphorus32 or tritium, has been used to follow disappearance
of granulocytes in the blood. Data of blood granulocyte half-life, ob-
tained in this way, agree quite well with estimates obtained from granulo-
kinetic data derived by other methods.' Since synovial exudate is free of
erythrocytes and platelets, it seemed reasonable that DFP injected directly
into the joint cavity would bind to granulocytes in the effusions. DFP
does bind to mononuclear cells in blood,5 but the synovial effusions are so
predominantly polymorphonuclear that the errors introduced by labeling
of other exudate cells are small.
There are several potential inadequacies in using this method to label
cells in synovial effusions: 1) continuing attachment of DFP to cells
over a period longer than the arbitrary one hour used in most of these
studies; 2) re-utilization of the label; 3) loss of fragile cells during the
repeated saline washes, a phenomenon that definitely occurs in rheumatoid
fluid6; 4) inadequate mixing in the total effusion when the label is in-
jected into the suprapatellar synovial extension only; and 5) labeling of
mononuclear phagocytes. Undoubtedly much of the variability noted
from point to point in the patients (Table 3) result from such problems
as variable loss of cells during washing and inadequate in vivo mixing.
The inherent and uncontrollable aspects of the method-incomplete
fixation of the label, re-utilization, tagging of mononuclear cells-all
tend to give more prolonged values for cell-associated labels. Only if
loose binding of the isotope occurred, a problem not encountered in the
many studies of blood leukocyte disappearance time,5'7 could the values
obtained in these experiments be shortened spuriously. Therefore, it would
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seem that these observations are a conservative estimate of true survival
time of granulocytes in these effusions.
These observations in patients with diverse synovial inflammatory
disease, then, probably indicate a rapid destruction of exudate granulocytes
in synovial effusions, regardless of the inflammatory stimulus. The half-
life of exudative granulocytes is only a few hours, with only a small
proportion of the original cells remaining after 24 hours. In chronic
effusions, therefore, there is a large daily destruction of cells and their
replacement from the blood, a turnover at least as great as the total
granulocytes in the effusions. In a quite average 30 ml. rheumatoid effusion
containing 25,000 granulocytes/cu.mm., the daily breakdown in the synovial
cavity might well exceed a billion cells.
SUMMARY
The lifespan of granulocytes in inflammatory synovial effusions has been
estimated by labeling cells with diisopropylfluorophosphate (DFP). Twelve
studies in nine patients with rheumatoid arthritis and six studies in patients
with other inflammatory joint disease were performed. The half-life of
the granulocytes was about four hours in the rheumatoid patients, and the
disappearance rate was similar in the other types of inflammatory synovitis.
RF.ERENCES
1. Bertino, J. R., Hollingsworth, J. W., and Cashmore, A. R.: Granulocyte
kinetics in rheumatoid effusions studied by a biochemical label. Trans. Ass.
Amer. Phycns., 1963, 76, 63-71.
2. Mokrasch, L. C. and McGilvery, R. W.: Purification and properties of fructose-1,
6-diphosphatase. J. biol. Chem., 1956, 221, 909-917.
3. Hayes, F. N., Ott, D. G., and Kerr, V. N.: Liquid scintillators. II. Pulse-height
comparison of secondary solutes. Nucleonics, 1956, 14, 42-45.
4. Athens, J. W., Raab, S. O., Haab, 0. P., Mauer, A. M., Ashenbrucker, H.,
Cartwright, G. E., and Wintrobe, M. M.: Leukokinetic studies. III. The
distribution of granulocytes in the blood of normal subjects. J. clin. Invest.,
1961, 40, 159-164.
5. Kurth, D., Athens, J. W., Cronkite, E. P., Cartwright, G. E., and Wintrobe,
M. M.: Leukokinetic studies. V. Uptake of tritiated diisopropylfluorophosphate
by leukocytes. Proc. Soc. exp. Biol. (N. Y.), 1961, 107, 422-426.
6. Bodel, P. T. and Hollingsworth, J. W.: Comparative morphology, respiration,
and phagocytic function of leukocytes from blood and joint fluid in rheuma-
toid arthritis. J. clin. Invest., 1966, 45, 580-589.
7. Athens, J. W.: Blood: Leukocytes. Ann. Rev. Physiol., 1963, 25, 195-212.
296